-

Implementing CSA for GxP Systems Training Course: Transition, Documentation, and Post-Transition Challenges and Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's offering.

The transition to Computer Software Assurance (CSA) marks a pivotal shift in the approach to compliance for FDA-regulated industries. This two-day seminar is designed to guide professionals in understanding the strategic and technical aspects of CSA implementation. With a focus on transitioning from the traditional Computer System Validation (CSV) methodology, the seminar covers risk-based validation, iterative approaches like Agile, and the integration of CSA principles into quality management systems (QMS).

Participants will explore how CSA enhances compliance by prioritizing critical thinking, risk-based assessments, and automation. The seminar delves into documentation strategies, continuous validation techniques, and overcoming post-transition challenges such as data integrity and regulatory communication. Attendees will also gain insights into leveraging CSA opportunities to optimize software quality, reduce validation costs, and ensure alignment with FDA's expectations.

Why You Should Attend:

This seminar is a must-attend for professionals aiming to master CSA implementation for GxP systems. Transitioning to CSA offers transformative benefits, but it demands a clear understanding of regulatory expectations, risk-based strategies, and effective documentation. You will gain expert insights into overcoming common challenges, ensuring data integrity, and integrating CSA into your quality systems.

Who Should Attend:

  • Information Technology Analysts
  • Information Technology Developers and Testers
  • QC/QA Managers and Analysts
  • Analytical Chemists
  • Compliance and Audit Managers
  • Laboratory Managers
  • Automation Analysts
  • Manufacturing Specialists and Managers
  • Supply Chain Specialists and Managers
  • Regulatory Affairs Specialists
  • Regulatory Submissions Specialists
  • Clinical Data Analysts
  • Clinical Data Managers
  • Clinical Trial Sponsors
  • Computer System Validation Specialists
  • GMP Training Specialists
  • Business Stakeholders/Subject Matter Experts
  • Business System/Application Testers
  • Consultants working in the life sciences industry

Key Topics Covered:

DAY 1 (10 AM to 3 PM)

  • Introduction to GxP systems and FDA's CSA framework
  • Comparison of CSA and traditional CSV methodologies
  • Exploring Agile and Waterfall approaches for validation
  • Fundamentals of risk-based validation and its applications
  • Documentation strategies for transitioning to CSA
  • CSA implementation for cloud-based and SaaS systems
  • Policies and procedures to support effective CSA adoption
  • Interactive Q&A session

DAY 2 (10 AM to 3 PM)

  • Identifying and addressing post-transition challenges
  • Continuous validation and automated testing for CSA
  • Risk assessments and prioritization strategies
  • Ensuring data integrity through CSA practices
  • Vendor audits and IT supplier assessments for CSA compliance
  • Preparing for FDA inspections and communicating CSA approaches
  • Case studies and practical examples of CSA success
  • Interactive Q&A session

Speaker

Carolyn Troiano has more than 30 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.

During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA's electronic record/electronic signature regulation.

Carolyn has participated in industry conferences. She is currently active in the PMI, AITP, and RichTech, and volunteers for the PMI's Educational Fund as a project management instructor for non-profit organizations.

For more information about this training visit https://www.researchandmarkets.com/r/iti9ii

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Artificial Intelligence in Healthcare Strategic Intelligence Report 2025: Transforming Healthcare Through Automation, Analytics, and Smarter Clinical Tools - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Strategic Intelligence: Artificial Intelligence in Healthcare (2025)" report has been added to ResearchAndMarkets.com's offering. Artificial intelligence (AI) is transforming healthcare through automation, analytics, and smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR)...

The Global Shape Memory Materials Market Report 2026: Technology Trends and Innovation Roadmap Through 2036 and 39 Profiles with Product Portfolios and Strategic Directions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Global Shape Memory Materials Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Shape Memory Materials Market 2026-2036 delivers an authoritative, data-driven analysis of one of advanced materials science's most dynamic sectors. This comprehensive market research report examines shape memory alloys (SMAs), shape memory polymers (SMPs), shape memory ceramics (SMCs), and emerging hybrid material systems that are revolutioniz...

Genome Editing Drugs Market Landscape Report 2025 with Spotlight on Casgevy - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Genome Editing Drugs Landscape" report has been added to ResearchAndMarkets.com's offering. This report investigates the impacts and development of Genome Editing therapies within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes within the market and how best to piv...
Back to Newsroom